Acne - Cystic Acne

Product NDC

55714-4469

11-digit product format

557144469

Labeler code

55714

Product ID

55714-4469_6c8ed581-8743-14dd-c7d6-c271d3bad811

Type

HUMAN PRESCRIPTION DRUG

Nonproprietary name

Antimon. crud., Arsenicum alb., Aur. met., Berber. aqui., Bovista, Carbo veg., Causticum, Chelidonium majus, Dulcamara, Graphites, Hepar sulph. calc., Hydrocotyle, Kali brom., Kali iod., Ledum, Lycopodium, Nux vom., Silicea, Sulphur iod., Zinc. met., Echinacea, Juglans regia, Lappa, Taraxacum

Dosage form

PELLET

Route

ORAL

Labeler

Newton Laboratories, Inc.

Marketing category

UNAPPROVED HOMEOPATHIC

Marketing start

2011-06-01

Marketing end

0000-00-00

Substance

ANTIMONY TRISULFIDE; ARSENIC TRIOXIDE; GOLD; MAHONIA AQUIFOLIUM ROOT BARK; GIANT PUFFBALL; ACTIVATED CHARCOAL; CAUSTICUM; CHELIDONIUM MAJUS; SOLANUM DULCAMARA TOP; GRAPHITE; CALCIUM SULFIDE; CENTELLA ASIATICA; POTASSIUM BROMIDE; POTASSIUM IODIDE; LEDUM PALUSTRE TWIG; LYCOPODIUM CLAVATUM SPORE; STRYCHNOS NUX-VOMICA SEED; SILICON DIOXIDE; SULFUR IODIDE; ZINC; ECHINACEA, UNSPECIFIED; ENGLISH WALNUT; ARCTIUM LAPPA ROOT; TARAXACUM OFFICINALE

Active strength

15 [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g

Pharmacologic classes

Non-Standardized Food Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [CS],Dietary Proteins [CS],Nut Proteins [EXT],Non-Standardized Plant Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Allergens [CS],Plant Proteins [CS],Seed Storage Proteins [CS],Standardized Chemical Allergen [EPC],Increased Histamine Release [PE],Allergens [CS],Cell-mediated Immunity [PE]

NDC exclude flag

No

Listing certified through

2019-12-31

Current FDA listing

Historical FDA.report record